Dauch reports Q3 2026 net loss of $42M to $47M
- Q3 2026 Adjusted EBITDA expected between $355M and $360M
- Full-year 2026 sales target raised to $10.8B to $10.875B
- Full-year 2026 Adjusted EBITDA target adjusted to $1.35B to $1.375B
DCH
Dauch reported Q3 2026 results on : dauch reports Q3 2026 net loss of $42M to $47M and full-year 2026 sales target raised to $10.8B to $10.875B.
Next: 10-Q due by Nov 9
Results, 8-Ks and Major or Notable filings come first, then registrations and share actions, then everything else, newest first. Routine filings are kept here unmarked; insider filings are summed up in one line.
Quarter ended Jun 30, 2026: revenue $3.0B (+92%), diluted EPS $0.00
Dauch Corporation (Dauch) issued a press release announcing that its represented workforce
Quarter ended Mar 31, 2026: revenue $2.4B (+69%), diluted EPS −$0.52
28 insider filings (Forms 3, 4, 5 and 144) in this list. Every DCH insider trade
Shelf registration; new shares or resale not read yet
Filed by MD Investors Corp · Filed by Oxford Forge, Inc. · +29 more
Filed by DME Capital Management, LP
Filed by FMR LLC
Filed by Dimensional Fund Advisors LP
Filed by Vanguard Group Inc
No listing notices in the 8-K item 3.01 filings SEC Tracker has read.
Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. All open notices
No trading halts for DCH since Feb 22, 2019, when SEC Tracker began reading the Nasdaq Trader feed.
Halt times and codes from the Nasdaq Trader trade halts feed, which lists Nasdaq and other exchange halts. Filings matched by SEC Tracker from EDGAR by company and time. Not investment advice. All recent halts
Fails-to-deliver: 4,341 shares on Aug 26, 2026, per SEC data
Stated dates are as each filing on EDGAR gives them; an expected date is estimated from the company's past filing dates, the same estimate as the top of the page. Not investment advice.
From the company's own filings; each row names its source. Not investment advice.